Andrew Edgecliffe-Johnson of the Financial Times writes Thursday that Bloomberg LP is joining forces with an online network for doctors to launch a service allowing investors in pharmaceutical companies to monitor and solicit physicians’ opinions on new drugs, medical devices and therapies.
“Daniel Palestrant, chief executive of Sermo, said he expected doctors to welcome the chance to share their opinions with investors. ‘The community is happiest when its voice is being heard,’ he said.
“Sachin Roopani, who developed Bloomberg’s healthcare service, said the Healthcare Exchange would provide investors with faster responses from a larger group than existing expert matching services.
“Bloomberg, which will share revenues from the service with Sermo, was looking to develop similar products for other industries, he added.”
Read more here.
The Advocate is looking for a savvy reporter to cover the Baton Rouge business scene…
MLex, a LexisNexis company, is an independent news organization for breaking news and forward-looking analysis…
The Austin Business Journal seeks a staff writer to cover economic development in one of…
A Russian court on Saturday placed Sergei Mingazov, a journalist for the Russian edition of…
Justin Nielsen of Investor's Business Daily writes about the newspaper's 40th anniversary. Nielsen writes, "When the…
Clare Fieseler has been hired by Politico and subsidiary E&E News to cover renewable energy,…
View Comments
Their terminal is phenomenal, and this new service is intriguing - as someone who tracks pharmaceutical stocks for a living, it will be interesting to see what sort of insights this might provide.